期刊文献+

骨转移癌微环境与治疗靶点 被引量:3

Microenvironment and therapeutic targets of metastatic bone cancer
原文传递
导出
摘要 目前骨转移癌的治疗手段相当有限,且疗效不显著.骨转移癌靶向治疗研究是当前的热点,同时也是难点.对骨微环境中成骨细胞、破骨细胞及肿瘤细胞等相互关系的最新研究成果,可为临床上治疗骨转移癌提供新的思路和方法. Currently,the treatment of bone metastases is quite limited,and the effect is not significant.It is a tempting but difficult task to find valid therapy.The recent research on bone microenvironment,including the osteoblasts,osteoclasts and tumor cells et al,may provide new targets and methods for the treatment of bone metastases.
出处 《国际肿瘤学杂志》 CAS 2014年第11期854-857,共4页 Journal of International Oncology
关键词 肿瘤转移 骨组织 靶向治疗 Neoplasm metastasis Bone tissue Targeted therapy
  • 相关文献

参考文献27

  • 1Suva L3, Washam C, Nicholas RW, et a|. Bone metastasis: mecha- nisms and therapeutic opportunities [ J ]. Nat Rev Endocrinol, 2011, 7(4) : 208-218.
  • 2Duda DG, Jaiu RK. Premetastatie lung "niche" : is vascular endothe- lial growth factor receptor 1 activation required? [ J]. Cancer Res, 2010, 70(14) :5670-5673.
  • 3Cupp ME, Nayak SK, Adem AS, et al. Parathyroid hormone (PTH) and PTH-related peptide domains contributing to activation of different PTH receptor-mediated signaling pathways [ J ]. J Pharmacol Exp Ther, 2013, 345(3):404-418.
  • 4Christopher MJ, Liu F, Hilton MJ, et al. Suppression of CXCL12production by bone marrow osteoblasts is a common and critical path- way for cytokine-induced mobilization [ J 1. Blood , 2009, 114 (7) : 1331-1339.
  • 5Shiozawa Y, Pedersen EA, Havens AM, et al. Human prostate canc- er metastases target the hematopoietic stem cell niche to establish foot- holds in mouse bone marrow[J]. J Clin Invest, 2011, 121 (4): 1298-1312.
  • 6Lu X, Wang Q, Hu G, et al. ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis [ J ]. Genes Dev, 2009, 23 ( 16 ) : 1882-1894.
  • 7Nannuru KC, Futakuchi M, Varney ML, et al. Matrix metalloprotein- ase (MMP)-13 regulates mammary tumor-induced osteolysis by acti- vating MMP9 and transforming growth factor-beta signaling at the tumor-bone interface[J]. Cancer Res, 2010, 70(9) :3494-3504.
  • 8Shevde LA, Das S, Clark DW, et al. Osteopontin: an effector and an effect of tumor metastasis[J]. Curt Mol Med, 2010, 10( 1 ) :71-81.
  • 9Ikushima H, Miyazono K. TGFbeta signalling: a complex web in cancer progression[ J]. Nat Rev Cancer, 2010, 10 (6) :415-424.
  • 10Dunn LK, Mohammad KS, Foumier PG, et al. Hypoxia and TGF-be- ta drive breast cancer bone metastases through parallel signaling path- ways in tumor cells and the bone microenvironment [ J ]. PLoS One, 2009, 4 ( 9 ) : e6896.

同被引文献33

引证文献3

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部